Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metronomic oral cyclophosphamide chemotherapy possibly contributes to stabilization of disease in patients with metastatic castration-resistant prostate cancer: a prospective analysis of consecutive cases.
Yashi M, Nishihara D, Mizuno T, Yuki H, Masuda A, Kambara T, Betsunoh H, Abe H, Fukabori Y, Muraishi O, Kamai T. Yashi M, et al. Among authors: fukabori y. Clin Genitourin Cancer. 2014 Oct;12(5):e197-203. doi: 10.1016/j.clgc.2014.02.007. Epub 2014 Mar 2. Clin Genitourin Cancer. 2014. PMID: 24674784
Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
Yashi M, Nukui A, Tokura Y, Takei K, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunoh H, Abe H, Fukabori Y, Nakazato Y, Kaji Y, Kamai T. Yashi M, et al. Among authors: fukabori y. BMC Urol. 2017 Jun 23;17(1):47. doi: 10.1186/s12894-017-0238-y. BMC Urol. 2017. PMID: 28645325 Free PMC article.
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density.
Nukui A, Kamai T, Arai K, Kijima T, Kobayashi M, Narimatsu T, Kambara T, Yuki H, Betsunoh H, Abe H, Fukabori Y, Yashi M, Yoshida KI. Nukui A, et al. Among authors: fukabori y. Cancer Immunol Immunother. 2020 May;69(5):689-702. doi: 10.1007/s00262-020-02499-7. Epub 2020 Feb 6. Cancer Immunol Immunother. 2020. PMID: 32030476 Free PMC article.
Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy.
Yashi M, Mizuno T, Yuki H, Masuda A, Kambara T, Betsunoh H, Abe H, Fukabori Y, Muraishi O, Suzuki K, Nakazato Y, Kamai T. Yashi M, et al. Among authors: fukabori y. BMC Urol. 2014 May 29;14:43. doi: 10.1186/1471-2490-14-43. BMC Urol. 2014. PMID: 24886065 Free PMC article.
Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.
Kobayashi M, Mizuno T, Yuki H, Kambara T, Betsunoh H, Nukui A, Abe H, Fukabori Y, Yashi M, Kamai T. Kobayashi M, et al. Among authors: fukabori y. Int J Clin Oncol. 2020 Mar;25(3):472-478. doi: 10.1007/s10147-019-01527-6. Epub 2019 Aug 22. Int J Clin Oncol. 2020. PMID: 31440861
96 results